Industry › Clinical Trials
Press Releases
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
Sirnaomics Ltd.
Jul 23, 2024 19:16 HKT/SGT
Sirnaomics宣布完成针对靶向APOC3用于治疗心血管疾病的STP125G 在非人灵长类动物模型中安全性和有效性的IND准备阶段研究
Sirnaomics Ltd.
Jul 23, 2024 18:26 HKT/SGT
Sirnaomics宣佈完成針對靶向APOC3用於治療心血管疾病的STP125G 在非人靈長類動物模型中安全性和有效性的IND準備階段研究
Sirnaomics Ltd.
Jul 23, 2024 17:52 HKT/SGT
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program
Avance Clinical
Jul 23, 2024 16:00 HKT/SGT
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Jun 21, 2024 18:30 HKT/SGT
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果，進一步展現熊去氧膽小檁鹼（HTD1801）的療效與安全性
HighTide Therapeutics Inc.
Jun 05, 2024 09:00 HKT/SGT
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
HighTide Therapeutics Inc.
Jun 05, 2024 09:00 HKT/SGT
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果，进一步展现熊去氧胆小檗碱（HTD1801）的疗效与安全性
HighTide Therapeutics Inc.
Jun 05, 2024 09:00 HKT/SGT
BIO24에서 발표된 새로운 연구에서 내부 규제 사항을 갖춘 CRO는 생명공학 기업에게 30%의 절감을 제공하고, 시간을 절반으로 줄이며, 위험을 줄입니다
Avance Clinical
Jun 04, 2024 22:56 HKT/SGT
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs
Avance Clinical
Jun 04, 2024 22:00 HKT/SGT
Avance Clinical通过与Julius Clinical合作，在欧洲扩展专门的中枢神经系统、心血管代谢和罕见疾病的CRO服务
Avance Clinical
Jun 01, 2024 06:00 HKT/SGT
Avance Clinical透過與Julius Clinical合作，在歐洲擴展專門的中樞神經系統、心血管代謝和罕見疾病的CRO服務
Avance Clinical
Jun 01, 2024 06:00 HKT/SGT